NM_001113525.2:c.*1693A>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_001113525.2(ZNF276):c.*1693A>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.459 in 1,604,774 control chromosomes in the GnomAD database, including 184,066 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.54 ( 25010 hom., cov: 33)
Exomes 𝑓: 0.45 ( 159056 hom. )
Consequence
ZNF276
NM_001113525.2 3_prime_UTR
NM_001113525.2 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.708
Publications
27 publications found
Genes affected
ZNF276 (HGNC:23330): (zinc finger protein 276) Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in kinetochore. [provided by Alliance of Genome Resources, Apr 2022]
FANCA (HGNC:3582): (FA complementation group A) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq, Jul 2008]
FANCA Gene-Disease associations (from GenCC):
- Fanconi anemia complementation group AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -18 ACMG points.
BP4
Computational evidence support a benign effect (REVEL=0.084).
BP6
Variant 16-89739939-A-T is Benign according to our data. Variant chr16-89739939-A-T is described in ClinVar as Benign. ClinVar VariationId is 135541.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.958 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ZNF276 | ENST00000443381.7 | c.*1693A>T | 3_prime_UTR_variant | Exon 11 of 11 | 1 | NM_001113525.2 | ENSP00000415836.2 | |||
| FANCA | ENST00000389301.8 | c.3934+55T>A | intron_variant | Intron 39 of 42 | 1 | NM_000135.4 | ENSP00000373952.3 |
Frequencies
GnomAD3 genomes AF: 0.542 AC: 82415AN: 152026Hom.: 24964 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
82415
AN:
152026
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.523 AC: 130329AN: 249378 AF XY: 0.509 show subpopulations
GnomAD2 exomes
AF:
AC:
130329
AN:
249378
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.451 AC: 654763AN: 1452630Hom.: 159056 Cov.: 41 AF XY: 0.452 AC XY: 325709AN XY: 720902 show subpopulations
GnomAD4 exome
AF:
AC:
654763
AN:
1452630
Hom.:
Cov.:
41
AF XY:
AC XY:
325709
AN XY:
720902
show subpopulations
African (AFR)
AF:
AC:
25754
AN:
33218
American (AMR)
AF:
AC:
28829
AN:
44180
Ashkenazi Jewish (ASJ)
AF:
AC:
8243
AN:
25888
East Asian (EAS)
AF:
AC:
38594
AN:
39462
South Asian (SAS)
AF:
AC:
50565
AN:
85924
European-Finnish (FIN)
AF:
AC:
24963
AN:
53210
Middle Eastern (MID)
AF:
AC:
1949
AN:
5726
European-Non Finnish (NFE)
AF:
AC:
447833
AN:
1105140
Other (OTH)
AF:
AC:
28033
AN:
59882
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
17637
35274
52910
70547
88184
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
14514
29028
43542
58056
72570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.542 AC: 82527AN: 152144Hom.: 25010 Cov.: 33 AF XY: 0.551 AC XY: 40988AN XY: 74358 show subpopulations
GnomAD4 genome
AF:
AC:
82527
AN:
152144
Hom.:
Cov.:
33
AF XY:
AC XY:
40988
AN XY:
74358
show subpopulations
African (AFR)
AF:
AC:
31641
AN:
41508
American (AMR)
AF:
AC:
8419
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
1119
AN:
3472
East Asian (EAS)
AF:
AC:
5077
AN:
5178
South Asian (SAS)
AF:
AC:
3005
AN:
4822
European-Finnish (FIN)
AF:
AC:
5087
AN:
10582
Middle Eastern (MID)
AF:
AC:
73
AN:
294
European-Non Finnish (NFE)
AF:
AC:
26810
AN:
67978
Other (OTH)
AF:
AC:
1013
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1738
3475
5213
6950
8688
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
688
1376
2064
2752
3440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2757
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Apr 09, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Fanconi anemia complementation group A Benign:1
Jul 08, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.